2FGV | pdb_00002fgv

X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.

CHAIN

A

Leucine aminopeptidase - Plasmodium falciparum 3D7

Explore Sequence Annotations in 3D

CHAIN A

UNIPROT Q8IL11

SECONDARY STRUCTURE

UNMODELED

EDS ATOMS

OCC WT AVG B

AVERAGE OCCUPANCY

ATOMIC CLASHES

ANGLE OUTLIERS

RSRZ

RSR

RSCC

CIS-PEPTIDE

BINDING SITE 1PE

BINDING SITE 1PE

BINDING SITE 1PE

BINDING SITE CO3

BINDING SITE DGZ

BINDING SITE DGZ

BINDING SITE DGZ

BINDING SITE SO4

BINDING SITE SO4

BINDING SITE SO4

BINDING SITE ZN

BINDING SITE ZN

METAL COORDINATION ZN

METAL COORDINATION ZN

BURIED RESIDUES

ARTIFACT

MUTATION

HYDROPATHY

DISORDER

DISORDERED BINDING

PFAM

CATH

ECOD

MOLECULE PROCESSING

ACTIVE SITE

MUTAGENESIS

SITE

REGION

LOADING 13%

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.